Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q5K654

Entry ID Method Resolution Chain Position Source
AF-Q5K654-F1 Predicted AlphaFoldDB

No variants for Q5K654

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q5K654

No associated diseases with Q5K654

16 regional properties for Q5K654

Type Name Position InterPro Accession
repeat HAT (Half-A-TPR) repeat 52 - 84 IPR003107-1
repeat HAT (Half-A-TPR) repeat 86 - 118 IPR003107-2
repeat HAT (Half-A-TPR) repeat 120 - 152 IPR003107-3
repeat HAT (Half-A-TPR) repeat 154 - 185 IPR003107-4
repeat HAT (Half-A-TPR) repeat 187 - 218 IPR003107-5
repeat HAT (Half-A-TPR) repeat 220 - 255 IPR003107-6
repeat HAT (Half-A-TPR) repeat 257 - 291 IPR003107-7
repeat HAT (Half-A-TPR) repeat 301 - 333 IPR003107-8
repeat HAT (Half-A-TPR) repeat 335 - 369 IPR003107-9
repeat HAT (Half-A-TPR) repeat 379 - 415 IPR003107-10
repeat HAT (Half-A-TPR) repeat 417 - 448 IPR003107-11
repeat HAT (Half-A-TPR) repeat 450 - 482 IPR003107-12
repeat HAT (Half-A-TPR) repeat 484 - 518 IPR003107-13
repeat HAT (Half-A-TPR) repeat 520 - 551 IPR003107-14
repeat HAT (Half-A-TPR) repeat 570 - 608 IPR003107-15
repeat Tetratricopeptide repeat 72 - 105 IPR019734

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
spliceosomal complex Any of a series of ribonucleoprotein complexes that contain snRNA(s) and small nuclear ribonucleoproteins (snRNPs), and are formed sequentially during the spliceosomal splicing of one or more substrate RNAs, and which also contain the RNA substrate(s) from the initial target RNAs of splicing, the splicing intermediate RNA(s), to the final RNA products. During cis-splicing, the initial target RNA is a single, contiguous RNA transcript, whether mRNA, snoRNA, etc., and the released products are a spliced RNA and an excised intron, generally as a lariat structure. During trans-splicing, there are two initial substrate RNAs, the spliced leader RNA and a pre-mRNA.

No GO annotations of molecular function

Name Definition
No GO annotations for molecular function

1 GO annotations of biological process

Name Definition
mRNA splicing, via spliceosome The joining together of exons from one or more primary transcripts of messenger RNA (mRNA) and the excision of intron sequences, via a spliceosomal mechanism, so that mRNA consisting only of the joined exons is produced.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MEASRGPPRV KNKAPAPQQI SAEQLLREAV DRQEPALQAP TQRFADLEEL HEYQGRKRKE
70 80 90 100 110 120
FEDYVRRNRI SMNNWMRYAQ WELEQKEFRR ARSVFERALD VDPTAVVLWI RYIEAEMKTR
130 140 150 160 170 180
NINHARNLLD RAVTIYSRVD KLWYKYVYME EMLGNIPGTR QVFERWMSWE PDEGAWGAYI
190 200 210 220 230 240
KLEKRYNEFD RVRAIFERFT VVHPEPKNWI KWARFEEEYG TSDMVREVYG LAIETLGEDF
250 260 270 280 290 300
MDEKLFIAYA RYEAKLKEFE RARAIYKYAL DRLPRAKSVA LHKAYTTFEK QFGDREGVED
310 320 330 340 350 360
VILSKRRVQY EEQIKENPKN YDIWFDFVRL EESSGDVERV RDVYERAIAQ MPPSQEKRHW
370 380 390 400 410 420
RRYIYLWIFY ALWEELEAKD MERAHQIYQE CIRLIPHKKF TFAKIWLMKA QFEIRQMDLQ
430 440 450 460 470 480
AARKTLGHAI GACPKDKLFK GYIDLERQLF EFVRCRKLFE KQIEWSPSNC QAWIKFAELE
490 500 510 520 530 540
RGLDDIDRAR AIYELGISQP VLDMPELLWK SYIDFEEYEG EYDRTRALYE RLLEKTNHVK
550 560 570 580 590 600
VWINFARFEI NIPEGEEEDE DEEEKPVSEE AKRRARMVFE RAHKVFKEKE MKEERVALLN
610 620 630 640 650 660
AWKSFEQTHG SPDDIAKIER QMPSKVKKRR KLDDDRYEEY LDYMFPADDE SSAKLSQILQ
670
MAHKWKKEQA SKASKET